KOLOA, Hawaii — Results showed use of Zynrelef as part of a multimodal analgesia protocol may significantly reduce pain and opioid use after total knee arthroplasty. “Zynrelef [bupivacaine and ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the fixed-dose combination of bupivacaine and meloxicam (Zynrelef) for the ...

PITTSBURGH, May 8, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive results from its Phase 3 program of the novel fast-acting formulation of ...

A single oral dose of SYMBRAVO provided rapid migraine pain freedom and return to normal functioning within 2 hours, and sustained efficacy through 24 and 48 hours 85% and 77% of patients treated with ...

A generic product for managing pain and inflammation associated with osteoarthritis (OA) in canines has been approved by FDA ...

CARLSBAD, Calif., Oct 18, 2011 (BUSINESS WIRE) -- Encore Therapeutics Inc. (ETI) today announced that it successfully completed a pre-clinical Proof of Concept (POC) study on ETI-511, its proprietary, ...

Meloxicam is a generic prescription drug approved for pain relief in certain animals, including dogs. Meloxicam belongs to the non-steroidal anti-inflammatory (NSAIDS) drug class. You may be able to ...

We evaluated the effect of pain mitigation strategies (isoflurane and meloxicam) on the behaviour and physiology of 3-week-old disbudded goat kids. Fifty Saanen does (mean ± SD, 21 ± 3 days old) were ...

Findings showed meloxicam/rizatriptan statistically significantly improved migraine treatment response compared with prior oral CGRP inhibitor treatment. Topline data were announced from a phase 3 ...

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...